Clinical Oncology
Five Year Prostate-specific Antigen Outcomes after Caesium Prostate Brachytherapy
Authors: R.M. Benoit, R.P. Smith, S. Beriwal
Published: 05/08/2014
<a href="https://isoray.com/research-category/brachytherapy/">Brachytherapy</a>, <a href="https://isoray.com/research-category/cesium-131/">Cesium-131</a>, <a href="https://isoray.com/research-category/featured/">Featured</a>, <a href="https://isoray.com/research-category/brachytherapy/prostate/">Prostate</a>

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center